Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Fatemeh Sadoughi, Parisa Maleki Dana, Zatollah Asemi & Bahman Yousefi. (2022) Targeting microRNAs by curcumin: implication for cancer therapy. Critical Reviews in Food Science and Nutrition 62:28, pages 7718-7729.
Read now
Read now
Badriyah Shadid Alotaibi, Manal Buabeid, Nihal Abdalla Ibrahim, Zelal Jaber Kharaba, Munazza Ijaz, Sobia Noreen & Ghulam Murtaza. (2021) Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature. International Journal of Nanomedicine 16, pages 7517-7533.
Read now
Read now
Zehra Edis, Junli Wang, Muhammad Khurram Waqas, Muhammad Ijaz & Munazza Ijaz. (2021) Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives. International Journal of Nanomedicine 16, pages 1313-1330.
Read now
Read now
Fangyuan Guo, Qiafan Fu, Chenhao Jin, Xugang Ji, Qinying Yan, Qingliang Yang, Danjun Wu, Ying Gao, Weiyong Hong, Aiqin Li & Gensheng Yang. (2019) Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment. Drug Delivery 26:1, pages 1027-1038.
Read now
Read now
Sheng Tan & Guoxiang Wang. (2017) Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo. Drug Design, Development and Therapy 11, pages 3519-3529.
Read now
Read now
Articles from other publishers (30)
Alaa S. Tulbah. (2023) In vitro bio-characterization of solid lipid nanoparticles of favipiravir in A549 human lung epithelial cancer cells. Journal of Taibah University Medical Sciences 18:5, pages 1076-1086.
Crossref
Crossref
Agnishwar Girigoswami & Koyeli Girigoswami. (2023) Potential Applications of Nanoparticles in Improving the Outcome of Lung Cancer Treatment. Genes 14:7, pages 1370.
Crossref
Crossref
Hafiz Saad Ahmad, Muhammad Ateeb, Sobia Noreen, Muhammad Irshad Farooq, Mirza Muhammad Faran Ashraf Baig, Muhammad Subhan Nazar, Muhammad Furqan Akhtar, Khalil Ahmad, Ali Raza Ayub, Hina Shoukat, Faheem Hadi & Asadullah Madni. (2023) Biomimetic synthesis and characterization of silver nanoparticles from Dipterygium glaucum extract and its anti-cancerous activities. Journal of Molecular Structure 1282, pages 135196.
Crossref
Crossref
Ting Xiong, Tao Guo, Yaping He, Zeying Cao, Huipeng Xu, Wenting Wu, Li Wu, Weifeng Zhu & Jiwen Zhang. (2022) Lactone Stabilized by Crosslinked Cyclodextrin Metal-Organic Frameworks to Improve Local Bioavailability of Topotecan in Lung Cancer. Pharmaceutics 15:1, pages 142.
Crossref
Crossref
Sobia Noreen, Jin-Xiang Ma, Muhammad Saeed, Fahad Pervaiz, Muhammad Farhan Hanif, Bilal Ahmed, Muhammad Irshad Farooq, Faizan Akram, Muhammad Safdar, Asadullah Madni, Muhammad Naveed & Li Chang-Xing. (2022) Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis. Drug Delivery and Translational Research 12:11, pages 2649-2666.
Crossref
Crossref
N. Prakashkumar, R. Mohamed Asik, T. Kavitha, G. Archunan & N. Suganthy. (2021) Unveiling the Anticancer and Antibiofilm Potential of Catechin Overlaid Reduced Graphene Oxide/Zinc Oxide Nanocomposites. Journal of Cluster Science 33:6, pages 2813-2830.
Crossref
Crossref
Hamid Reza Nejabati & Leila Roshangar. (2022) Kaempferol: A potential agent in the prevention of colorectal cancer. Physiological Reports 10:20.
Crossref
Crossref
Rui Han, Youhong Guan, Min Li, Aiqun Xu, Dong Wu, Pulin Li, Enze Wang, Peng Sun, Guanghe Fei, Sijing Zhou & Ran Wang. (2022) Efficacy and Safety of Nanoadministration in the Treatment of Non-Small-Cell Lung Cancer Is Good to Some Extent: A Systematic Review and Meta-Analysis. Journal of Oncology 2022, pages 1-11.
Crossref
Crossref
Jundong Wang, Tianhao Li, Chaochi Yue, Sen Zhong, Xiangdong Yang, Jun Li & Yuanzhi Li. (2021) Preparation of nanoparticles of β-cyclodextrin-loaded scutellarein anti-tumor activity research by targeting integrin αvβ3. Cancer Nanotechnology 12:1.
Crossref
Crossref
Xinglong Fan, Tian Wang, Zhongyi Ji, Qingpeng Li, Hongyu Shen & Jun Wang. (2021) Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles. Biomedicine & Pharmacotherapy 141, pages 111830.
Crossref
Crossref
Joydeb Majumder & Tamara Minko. (2021) Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations. Pharmaceutics 13:7, pages 1063.
Crossref
Crossref
Denish Bardoliwala, Ankit Javia, Saikat Ghosh, Ambikanandan Misra & Krutika Sawant. (2021) Formulation and clinical perspectives of inhalation-based nanocarrier delivery: a new archetype in lung cancer treatment. Therapeutic Delivery 12:5, pages 397-418.
Crossref
Crossref
Muthupandian Saravanan, Hamed Barabadi, Hossein Vahidi, Thomas J. Webster, David Medina-Cruz, Ebrahim Mostafavi, Ada Vernet-Crua, Jorge Luis Cholula-Diaz & Prakash Periakaruppan. 2021. Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications. Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications
439
456
.
Yaping He, Ting Xiong, Siyu He, Hongyu Sun, Chenxi Huang, Xiaohong Ren, Li Wu, Laurence H. Patterson & Jiwen Zhang. (2020) Pulmonary Targeting Crosslinked Cyclodextrin Metal–Organic Frameworks for Lung Cancer Therapy. Advanced Functional Materials 31:3, pages 2004550.
Crossref
Crossref
Xuefeng Tang, Zhao Wang, Feng Wei, Wei Mu & Xiaojun Han. (2020) Recent Progress of Lung Cancer Diagnosis Using Nanomaterials. Crystals 11:1, pages 24.
Crossref
Crossref
Jigar D. Vanza, Rashmin B. Patel & Mrunali R. Patel. (2020) Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer. Journal of Drug Delivery Science and Technology 60, pages 102070.
Crossref
Crossref
Xavier Montané, Anna Bajek, Krzysztof Roszkowski, Josep M. Montornés, Marta Giamberini, Szymon Roszkowski, Oliwia Kowalczyk, Ricard Garcia-Valls & Bartosz Tylkowski. (2020) Encapsulation for Cancer Therapy. Molecules 25:7, pages 1605.
Crossref
Crossref
Hamed Barabadi, Hossein Vahidi, Kaveh Damavandi Kamali, Omid Hosseini, Mohammad Ali Mahjoub, Masoumeh Rashedi, Fereshteh Jazayeri Shoushtari & Muthupandian Saravanan. (2019) Emerging Theranostic Gold Nanomaterials to Combat Lung Cancer: A Systematic Review. Journal of Cluster Science 31:2, pages 323-330.
Crossref
Crossref
Luyao Wang, Qingxia Ma, Ruixue Yao & Jia Liu. (2020) Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer. International Immunopharmacology 79, pages 106088.
Crossref
Crossref
Parijat Pandey, Meenu Mehta, Shakti Shukla, Ridhima Wadhwa, Gautam Singhvi, Dinesh Kumar Chellappan, Saurabh Satija, Gaurav Gupta, Rajendra Awasthi, Parteek Prasher, Philip M. Hansbro, Kamal Dua & Harish Dureja. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
449
468
.
Caleb F. Anderson, Maria E. Grimmett, Christopher J. Domalewski & Honggang Cui. (2019) Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. WIREs Nanomedicine and Nanobiotechnology 12:1.
Crossref
Crossref
Alaa S. Tulbah, Elvira Pisano, Emelie Landh, Santo Scalia, Paul M. Young, Daniela Traini & Hui Xin Ong. (2019) Simvastatin Nanoparticles Reduce Inflammation in LPS-Stimulated Alveolar Macrophages. Journal of Pharmaceutical Sciences 108:12, pages 3890-3897.
Crossref
Crossref
A. Singh, S. Bhatia & V. Rana. (2019) Inhalable Nanostructures for Lung Cancer Treatment: Progress and Challenges. Current Nanomedicine 9:1, pages 4-29.
Crossref
Crossref
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2019. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy
129
161
.
Bushra Riyaz, Kalvatala Sudhakar & Vijay Mishra. 2019. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer
311
326
.
Andreia Carvalho, Alexandra R. Fernandes & Pedro V. Baptista. 2019. Applications of Targeted Nano Drugs and Delivery Systems. Applications of Targeted Nano Drugs and Delivery Systems
257
295
.
Fangyuan Guo, Jiangqing Wu, Wenchao Wu, Dongxue Huang, Qinying Yan, Qingliang Yang, Ying Gao & Gensheng Yang. (2018) PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors. Journal of Nanobiotechnology 16:1.
Crossref
Crossref
Guowen Wang, Zuyi Wang, Chuankui Li, Guixin Duan, Kangwu Wang, Qicai Li & Tao Tao. (2018) RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy. Biomedicine & Pharmacotherapy 106, pages 275-284.
Crossref
Crossref
Dan Zhao, Changyue Xue, Qianshun Li, Mengting Liu, Wenjuan Ma, Tengfei Zhou & Yunfeng Lin. (2018) Substrate stiffness regulated migration and angiogenesis potential of A549 cells and HUVECs. Journal of Cellular Physiology 233:4, pages 3407-3417.
Crossref
Crossref
Bomi Kim, Bohyung Seo, Sanghyun Park, Changkyu Lee, Jong Oh Kim, Kyung Taek Oh, Eun Seong Lee, Han-Gon Choi & Yu Seok Youn. (2017) Albumin nanoparticles with synergistic antitumor efficacy against metastatic lung cancers. Colloids and Surfaces B: Biointerfaces 158, pages 157-166.
Crossref
Crossref